NCT06692582

Brief Summary

The study will be conducted as a prospective, double-blind, parallel, randomized, placebo-controlled study at the Dental Clinic of University Medical Centre Ljubljana. It will involve a one-month test period, during which the test subjects will use either placebo, Electrolysed Oxidising Saline (EOS) or chlorhexidine (CHX) in the form of a mouthwash as an adjunct to the non-surgical treatment of chronic periodontitis (i.e. root planing and scaling). We will include 60 subjects who will be selected from consecutively scheduled patients referred by their personal dentists for periodontal treatment at the Dental Clinic of University Medical Centre Ljubljana.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jun 2024Dec 2026

Study Start

First participant enrolled

June 6, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2026

Expected
Last Updated

November 18, 2024

Status Verified

November 1, 2024

Enrollment Period

1.5 years

First QC Date

November 14, 2024

Last Update Submit

November 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • No of residual diseased sites

    Probing Pocket Depth (PPD) \> 4 mm + Bleeding On Probing (BOP)

    Baseline, 1 month, 3 months

Secondary Outcomes (3)

  • Probing Pocket Depth (PPD)

    Baseline, 1 month, 3 months

  • Clinical Attachment Level (CAL)

    Baseline, 1 month, 3 months

  • Full Mouth Plaque Score (FMPS)

    Baseline, 1 month, 3 months

Other Outcomes (1)

  • Absolute number and share of 14 periodontopathogenic species

    Baseline, 1 month, 3 months

Study Arms (3)

EOS

EXPERIMENTAL
Other: Electrolysed saline rinse

CHX

ACTIVE COMPARATOR
Other: Electrolysed saline rinse

Placebo - distilled water

PLACEBO COMPARATOR
Other: Electrolysed saline rinse

Interventions

EOS ph = 7, 200 ppm free available Chlorine

CHXEOSPlacebo - distilled water

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical attachment loss ≥ 5 mm on at least two teeth in two different jaw quadrants; presence of stable occlusion and at least 16 teeth, among which at least 12 teeth are suitable for evaluation (excluding wisdom teeth, teeth with orthodontic wires, bridges, crowns, and implants).

You may not qualify if:

  • We will exclude individuals who: suffer from chronic systemic diseases (diabetes, cancer, HIV infection, metabolic bone diseases, and diseases that interfere with wound healing processes); are undergoing radiation or chemotherapy; are taking immunosuppressants, antiepileptic drugs, calcium antagonists, nonsteroidal anti-inflammatory drugs; have been treated with antibiotics in the past 12 months; have a known allergy to CHX; have undergone scaling and root planing or surgical periodontal treatment in the past year; are pregnant or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre Ljubljana

Ljubljana, 1000, Slovenia

RECRUITING

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Central Study Contacts

Rok Gašperšič, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomization will be performed using a computer program. Only one member of the research group, who will also prepare the mouthwashes, will know the content of the randomization table or the type of mouthwash used by each individual. Identification codes will remain hidden from all other researchers and subjects until the final follow-up examinations. The packaging of the mouthwashes will be identical, and the active ingredients will not be distinguishable by color.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2024

First Posted

November 18, 2024

Study Start

June 6, 2024

Primary Completion

December 6, 2025

Study Completion (Estimated)

December 6, 2026

Last Updated

November 18, 2024

Record last verified: 2024-11

Locations